
Sariant Therapeutics provides software that helps drug developers locate druggable DNA regulatory elements involved in cancer. It uses AI to analyze cancer-specific chromatin looping and DNA folding at high resolution. The platform is designed for biopharma and biotech R&D teams. This approach aims to expand the set of druggable targets and accelerate development of targeted cancer medicines.

Sariant Therapeutics provides software that helps drug developers locate druggable DNA regulatory elements involved in cancer. It uses AI to analyze cancer-specific chromatin looping and DNA folding at high resolution. The platform is designed for biopharma and biotech R&D teams. This approach aims to expand the set of druggable targets and accelerate development of targeted cancer medicines.